The United States holds a prominent position in the bioabsorbable stents sector, driven by the high prevalence of cardiovascular diseases and the strong adoption of advanced medical technologies. The increasing number of patients suffering from coronary artery disease, coupled with a growing elderly population, continues to generate demand for innovative interventional cardiology solutions. The...